<DOC>
	<DOCNO>NCT00152373</DOCNO>
	<brief_summary>clinical efficacy safety Levetiracetam add-on therapy adult Chinese subject partial seizure .</brief_summary>
	<brief_title>Double-blind , Placebo-controlled Study Levetiracetam Adults With POS</brief_title>
	<detailed_description />
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Epilepsies , Partial</mesh_term>
	<mesh_term>Etiracetam</mesh_term>
	<mesh_term>Piracetam</mesh_term>
	<criteria>1. subject suffer partial onset seizure , whether secondarily generalize , 2. presence follow eight week historical baseline period : least eight partial seizure ( type IA , IB IC ) without secondary generalization . 3. subject stable dose least one two concomitant antiepileptic drug ( AEDs ) . 4. subject expose least one classical AEDs , 5 . CT scan MRI perform within last 2 year free neoplasia , progressive cerebral disease progressively neurodegenerative disease . 1. history status epilepticus within three month prior Selection visit , 2. subject whose seizure reliably count regular basis due fast repetitive occurrence ( cluster flurry ) , 3. use medication ( concomitant AED ) influence central nervous system ( CNS ) unless stable regimen least 1 month prior Selection visit . Antidepressants ( except amitriptyline , mianserin fluoxetine ) , anxiolytic hypnotic allow . Intermittent benzodiazepine allow long frequency great one single administration per week least 3 month prior Selection visit . Neuroleptics Traditional Chinese AEDs allowed. , 4. history presence pseudoseizures ,</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>Epilepsy , Partial Onset Seizures ; Keppra ; Levetiracetam</keyword>
</DOC>